Skip to main navigation

Main Menu
About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers
Amgen Worldwide

Overview
Research and Development Strategy
Overview <i class="fa fa-external-link"></i>
Scientific Advisory Boards
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Clinical Trials
Scientific Community Initiatives   
Manufacturing

Overview
About Clinical Trails
Amgen Clinical Trails<i class="fa fa-external-link"></i>
Clinical Study Report Synopses<i class="fa fa-external-link"></i>
Clinical Trial Diversity
Lay Summary of Clinical Trail Result<i class="fa fa-external-link"></i>
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies<i class="fa fa-external-link"></i>

All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags

COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities

About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers

Breadcrumb

Home
Investors
Reconciliations

Reconciliations

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

05.18.2021

2021 Annual Meeting of Stockholders Presentation 306.3 KB

09.18.2020

Form 8937 293.7 KB

05.19.2020

Q4 2019 Financial Results 212.4 KB

Navbar w/ text

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

Earnings

Show all

Q2 2021

Q2 2021 Amgen Earnings Conference Call
Q2 2021 Earnings Presentation 1.7 MB
Amgen Reports Second Quarter 2021 Financial Results

Data as of:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stay Connected With Amgen.

Contact Us Sitemap Privacy Statement Terms of Use

© 1996-2020 Amgen Inc. All Rights Reserved.